Metraipolis › archive › dc_bd32bfd91eaf

Enhancing Cardiovascular Risk Prediction in Type 2 Diabetes: The Role of NT-proBNP as a Prognostic Biomarker — Europe PMC PMID:41141071

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41141071
DOI
10.7759/cureus.92997
License (as archived)
solo-consultazione
Archived
2026-11-09T19:06:06.823Z
SHA-256 of the archived text
a79914acfbdc437648a15894a05c9af94f4133279c9b1680acb9a95efbd343ea
Stable URL of this page
https://metraipolis.com/documento/dc_bd32bfd91eaf

How to cite

Enhancing Cardiovascular Risk Prediction in Type 2 Diabetes: The Role of NT-proBNP as a Prognostic Biomarker — Europe PMC PMID:41141071 — Europe PMC (en), https://europepmc.org/article/MED/41141071 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bd32bfd91eaf (Metraipolis archive dc_bd32bfd91eaf, sha256 a79914acfbdc437648a15894a05c9af94f4133279c9b1680acb9a95efbd343ea)
BibTeX
@misc{dcbd32bfd91eaf,
  title = {Enhancing Cardiovascular Risk Prediction in Type 2 Diabetes: The Role of NT-proBNP as a Prognostic Biomarker — Europe PMC PMID:41141071},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41141071},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bd32bfd91eaf; sha256 a79914acfbdc437648a15894a05c9af94f4133279c9b1680acb9a95efbd343ea},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41141071. Agents can read the archived copy with the MCP tool read_document.